Nanobiotechnology and non-viral gene delivery

Munia Ganguli

Scientist-G  |  Decision Unit 3: Chemical Biology
Professor  |  Academy of Scientific and Innovative Research

Portrait of Munia Ganguli

Munia Ganguli works on designing nanoparticles for efficient and safe therapeutic cargo delivery. The primary focus is localized and systemic delivery of nucleic acids in vivo to organs like skin, muscle, and brain using designed peptides and polymers. The lab also develops functionalized nanoparticles for applications ranging from UV protection to cancer drug delivery.

Specific Interests

  • Peptide & polymer-based nanocomplexes for gene delivery
  • Safe delivery of therapeutic nucleic acids to skin and muscle
  • Functionalized nanoparticles for biomedical applications

The group has developed peptide-based nanocomplexes for gene delivery and polymer systems capable of crossing the blood-brain barrier. Current work includes mRNA delivery and CRISPR-Cas9 based gene editing. They have also developed UV protectants and cold-protection systems for skin applications.

Selected Publications

All Citations →